Twitxy Saved

Luca Arecco, MD

@Lucarecco

Medical Oncologist @UniGenova🇮🇹 | @myESMO Clinical Research Fellow @JulesBordet Institute 🇧🇪| Focused on Breast Cancer, Fertility and Survivorship
Brussels, Belgium linkedin.com/in/luca-arecco… Joined February 2020
614 Following 1.7K Followers 1.7K Posts

Latest posts 5

Luca Arecco, MD @Lucarecco
The final and complete @OncoAlert newsletter from @myESMO Madrid 2026 is out now! Check it here!👇🏼
#ESMO26 @myESMO
OncoAlert Verified account @OncoAlert Oct 26
Dear colleagues,
We are already curating THE COMPLETE #ESMO26 NEWSLETTER 📰 our picks of the top trials presented in Madrid, together in one email.

Register to receive it 👉 buff.ly/N5gYtAc

Every newsletter is curated by oncologists, for colleagues working in cancer care. It’s our way of making science quick and accessible.

We are OncoAlert🚨 For Colleagues, by Colleagues

Best,
The Network

@cdanicas @hoperugo @DrChoueiri @TiansterZhang @matteolambe @NiuSanford @stolaney1 @christine_lovly @amerseburger @GlopesMd @tompowles1 @montypal @Icro_Meattini @PGrivasMDPhD @brian_rini @CathyEngMD @apolo_andrea @AndreaNecchi @DrSGraff @BenWestphalen @graokane @to_be_elizabeth @ElisaAgostinett @nataliagandur @UOzkerim @DrMirallas @DrYukselUrun @Lucarecco @mzugman @HHorinouchi @p_ciracimd @DraMartinezLago @DrVilmaPBarcia @GIMedOnc @MarioBalsaMD @scocmem @AmandaNizamMD @GaiaGriguolo @JankovicK @Dr_Oncologista @Erman_Akkus @WeOncologists @niklas_kluemper @Markuseckstein3
View quoted post on X
0 replies 7 reposts 14 likes 689 views View on X
Luca Arecco, MD @Lucarecco
Here is our Top 10 Breast Cancer abstracts of #ESMO2026 from the @OncoAlert faculty!
👇👇👇👇
OncoAlert Verified account @OncoAlert Oct 20
🚨 #ESMO26 Breast Cancer: Top Ten by @OncoAlert 🎗️

The abstracts our faculty flagged as must-know from MADRID🇪🇸 👇

1️⃣ PANKU-Breast01 (LBA50): iza-bren in HR+/HER2− mBC
2️⃣ FOURLIGHT-1 (1842O): atirmociclib + fulvestrant post-CDK4/6i
3️⃣ NATALEE (LBA25): 6-year OS for adjuvant ribociclib
4️⃣ APEX-Breast01 (LBA27): TQB2102 in HER2-low
5️⃣ KEYNOTE-B49 (LBA51): pembro + chemo in HR+/HER2−
6️⃣ HORIZON-Breast06 (LBA13): SHR-A1811 in HER2-low
7️⃣ POP-DURVA (LBA26): preop durvalumab in stage I TNBC
8️⃣ SWITCH (4RO): ADC target switching after prior ADC
9️⃣ postMONARCH (1RO): OS for abemaciclib + fulvestrant
🔟 DESTINY-Breast09 (LBA49): T-DXD + P with baseline brain mets

#BreastCancer

@matteolambe @aftimosp @E_de_Azambuja @DrSGraff @ErikaHamilton9 @hoperugo @stolaney1 @BianchiniGP @aftimosp @kevinpunie @ElisaAgostinett @to_be_elizabeth @GaiaGriguolo @JankovicK

@double_whammied @maryam_lustberg @raalbany @JavierCortesMD @JaniceTNBCmets @Prof_Nadia_H @LoiSher @SirohiBhawna @jamecancerdoc

@nataliagandur @acampsmalea @FernandoOnco @realbowtiedoc @Lucarecco @AmandaNizamMD @scocmem @MarioBalsaMD @Dr_Oncologista
View quoted post on X
0 replies 11 reposts 24 likes 1.6K views View on X